as on
| Source : NSE
as on August 22, 2025 at 2:54 PM IST
Day's Low
Day's High
1.21%
Downside
2.24%
Upside
52 Week's Low
52 Week's High
18.92%
Downside
60.44%
Upside
Market Stats | |
Previous Close | ₹17.40 |
Open | ₹17.39 |
Volume | 2.37L |
Upper Circuit | ₹18.27 |
Lower Circuit | ₹16.53 |
Day's Low | ₹17.18 |
Day's High | ₹17.78 |
52 Week Low | ₹14.1 |
52 Week High | ₹27.9 |
Returns % | |
1 Month Return | -4.19 % |
3 Month Return | -11.72 % |
1 Year Return | -5.95 % |
3 Year Return | + 106.41 % |
5 Year Return | + 850.82 % |
Check Syncom Formulations (India) Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,635.60 Cr
Return on Equity (ROE)
8.71
PE Ratio (TTM)
25.97
Return on capital employed (ROCE)
10.32
Industry PE ratio
43.37
Beta (LTM)
1.41
P/B Ratio
3.67
Dividend Yield
0PEG Ratio
89.55
Quarterly Earnings Growth YOY
106.42
EPS (TTM)
0.27
Sector
Pharmaceuticals
Book Value
3.07
Technical Analysis
Bearish
View Technical Analysis
Track how Syncom Formulations (India) Ltd P/E has moved over time to understand its valuation trends.
Syncom Formulations (India) Ltd in the last 5 years
Lowest (3.98x)
March 12, 2020
Today (25.97x)
August 21, 2025
Industry (43.37x)
August 21, 2025
Highest (81.74x)
January 18, 2022
Today’s Price to Earnings Ratio: 25.97x
Get the annual and quarterly financial summary of Syncom Formulations (India) Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Syncom Formulations (India) Ltd.
Syncom Formulations (India) Ltd’s net profit jumped 106.42% since last year same period to ₹15.75Cr in the Q1 2025-2026. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated -10.97% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 per share on 13 Aug 2022 - translating a dividend yield of 0.17%.
Read More about DividendsCheck stock indices that include Syncom Formulations (India) Ltd.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Syncom Formulations (India) Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 50.57% | 0.00 | |
Foreign Institutions | 0.41% | 278.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 49.02% | ||
Others | 0% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Syncom Formulations (India) Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 1,635.60 | 170.16% | 0.61 | 25 | 263 | |
NA | 219.61 | 409.45% | 0.56 | -12 | 15 | |
NA | 137.71 | -11.79% | 0.00 | 12 | 69 | |
NA | 8.28 | 8.75% | 0.76 | NA | 27 | |
NA | 264.04 | 0.76% | 0.00 | 9 | 162 |
Latest news and events in one place to help you make informed investing decisions in Syncom Formulations (India) Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.11% to 0.41% in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 28.7%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 32.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.57% of holdings in Jun 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 155.83 Cr → 122.98 Cr (in ₹), with an average decrease of 21.1% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 49.32% to 49.02% in Jun 2025 quarter
Profit Down
Netprofit is down for the last 2 quarters, 17.69 Cr → 15.75 Cr (in ₹), with an average decrease of 11.0% per quarter
Price Dip
In the last 3 months, SYNCOMF stock has moved down by -11.7%
Organisation | Syncom Formulations (India) Ltd |
Headquarters | Indore |
Industry | Pharmaceuticals |
CEO | Kedarmal Bankda |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Syncom Formulations (India) Ltd.
Funds | Holdings | Prev. 5M |
---|---|---|
Bandhan BSE Healthcare Index Fund Direct Growth | 0.06% |
Syncom Formulations (India) Ltd share price today stands at ₹17.39, Open: ₹17.39, Previous Close: ₹17.4, High: ₹17.78, Low: ₹17.18, 52 Week High: ₹27.9, 52 Week Low: ₹14.1 as on .
To buy Syncom Formulations (India) Ltd shares, you need to follow these steps:
Today's traded volume of Syncom Formulations (India) Ltd is 2.37L. Which means that 2.37L shares of Syncom Formulations (India) Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Syncom Formulations (India) Ltd is ₹1,635.60 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Syncom Formulations (India) Ltd’s 52 week high is ₹27.9 and 52 week low is ₹14.1. The current share price of Syncom Formulations (India) Ltd is ₹17.39, which is -37.67% down from its 52 week high and 23.33% up from its 52 week low.